Search research articles
Contact Us
Filters
Showing results (441-450 of 706) with videos related to
Page
of 71
Sort By:
Clinical Science (London, England : 1979)
|
September 29, 2004
Cardiovascular risk factors and endothelial dysfunction
Anthony S Wierzbicki, Philip J Chowienczyk, John R Cockcroft, et al.
Journal of Lipid Research
|
June 23, 2009
Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III
Doris T Chan, Gursharan K Dogra, Ashley B Irish, et al.
Metabolism: Clinical and Experimental
|
April 3, 2020
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
Gerald F Watts, Dick C Chan, Jing Pang, et al.
Diabetes Care
|
August 5, 2009
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome
Dick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Atherosclerosis
|
May 13, 2014
Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner
Damon A Bell, Amanda J Hooper, Glenn Edwards, et al.
Asia Pacific Journal of Clinical Nutrition
|
November 29, 2007
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome
Esther M M Ooi, Gerald F Watts, P Hugh R Barrett, et al.
Clinical Science (London, England : 1979)
|
May 17, 2006
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome
Gerald F Watts, Juying Ji, Dick C Chan, et al.
Prostaglandins & Other Lipid Mediators
|
March 27, 2018
The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease
Anne E Barden, Sujata Shinde, Valerie Burke, et al.
Pharmacoeconomics
|
January 24, 2024
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review
Clara Marquina, Jedidiah I Morton, Melanie Lloyd, et al.
Journal of the American Heart Association
|
March 17, 2020
Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease
Jonathan Golledge, Sophie Rowbotham, Ramesh Velu, et al.
Page
of 71
Search research articles
Search
Showing results (441-450 of 706) with videos related to
Sort By:
Page
of 71
Clinical Science (London, England : 1979)
|
September 29, 2004
Cardiovascular risk factors and endothelial dysfunction
Anthony S Wierzbicki, Philip J Chowienczyk, John R Cockcroft, et al.
Journal of Lipid Research
|
June 23, 2009
Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III
Doris T Chan, Gursharan K Dogra, Ashley B Irish, et al.
Metabolism: Clinical and Experimental
|
April 3, 2020
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
Gerald F Watts, Dick C Chan, Jing Pang, et al.
Diabetes Care
|
August 5, 2009
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome
Dick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Atherosclerosis
|
May 13, 2014
Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner
Damon A Bell, Amanda J Hooper, Glenn Edwards, et al.
Asia Pacific Journal of Clinical Nutrition
|
November 29, 2007
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome
Esther M M Ooi, Gerald F Watts, P Hugh R Barrett, et al.
Clinical Science (London, England : 1979)
|
May 17, 2006
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome
Gerald F Watts, Juying Ji, Dick C Chan, et al.
Prostaglandins & Other Lipid Mediators
|
March 27, 2018
The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease
Anne E Barden, Sujata Shinde, Valerie Burke, et al.
Pharmacoeconomics
|
January 24, 2024
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review
Clara Marquina, Jedidiah I Morton, Melanie Lloyd, et al.
Journal of the American Heart Association
|
March 17, 2020
Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease
Jonathan Golledge, Sophie Rowbotham, Ramesh Velu, et al.
Page
of 71